Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Register of Innovative Drugs - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 211673
Later capture
Register of Innovative Drugs - Canada.ca
Jan 1, 2026
hc-20260101
ID 404925
updated6 sections changed
6 sections changed0 added0 removed+106 / -120 linesChange ratio: 8%
--- +++ @@ -1,8 +1,9 @@ Register of Innovative Drugs Guidance Document: Data Protection under C.08.004.1 of the Food and Drug Regulations [2010-03-08]-Register Of Innovative Drugs [Updated: 2025-04-15]-(PDF, 290 KB)+Do not change this link. Replace what is in the dam+Register Of Innovative Drugs [Updated: 2025-12-23]+(PDF, 296 Kb) Contact: Office of Patented Medicines and Liaison Products for Human Use - Active Data Protection Period@@ -18,8 +19,7 @@ Innovative Drug Manufacturer Drug(s) Containing the Medicinal Ingredient / Variations-Notice of Compliance Date-yyyy-mm-dd+Notice of Compliance Date yyyy-mm-dd 6 Year "No File" Date@@ -77,8 +77,8 @@ N/A 2020-07-31 2026-07-31-N/A-2028-07-31+Yes+2029-01-31 amivantamab 254440 Rybrevant@@ -97,15 +97,6 @@ 2029-06-16 N/A 2031-06-16-mRNA encoding SARS-CoV-2 spike protein, 5'(m7G-5'-ppp-5'-Gm) cap, 100-nucleotide 3' poly(A) tail-275936-Spikevax-Moderna Biopharma Canada Corporation-N/A-2023-09-12-2029-09-12-Yes-2032-03-12 anifrolumab 246187 Saphnelo@@ -133,15 +124,6 @@ 2023-11-06 Yes 2026-05-06-antihemophilic factor (recombinant), pegylated-189709-Adynovate-Takeda Canada Inc.-N/A-2016-11-17-2022-11-17-Yes-2025-05-17 antihemophilic factor (recombinant, B-domain deleted, pegylated) (also known as damoctocog alfa pegol) 210935 Jivi@@ -158,17 +140,8 @@ N/A 2025-03-26 2031-03-26-N/A-2033-03-26-antihemophilic factor VIII (recombinant), singlechain (also known as lonoctocog alfa)-190891-Afstyla-CSL Behring Canada Inc.-N/A-2016-12-12-2022-12-12-Yes-2025-06-12+Yes+2033-09-26 antihemophilic factor VIII (recombinant, B-domain truncated), PEGylated (turoctocog alfa pegol) 218531 Esperoct@@ -187,6 +160,15 @@ 2024-07-03 N/A 2026-07-03+artesunate+285622+Amivas - Artesunate+Amivas Ireland Ltd.+N/A+2025-07-04+2031-07-04+Yes+2034-01-04 asciminib hydrochloride 255700 Scemblix@@ -196,15 +178,6 @@ 2028-06-23 N/A 2030-06-23-atezolizumab-196843-Tecentriq-Hoffmann-La Roche Limited-N/A-2017-04-12-2023-04-12-Yes-2025-10-12 atogepant 253186 Qulipta@@ -286,6 +259,15 @@ 2024-08-17 N/A 2026-08-17+belantamab mafodotin+288908+Blenrep+GlaxoSmithKline Inc.+N/A+2025-07-18+2031-07-18+N/A+2033-07-18 belumosudil mesylate 245791 Rezurock@@ -304,6 +286,15 @@ 2028-07-11 N/A 2030-07-11+bempedoic acid+291745+Nilemdo+HLS Therapeutics Inc.+N/A+2025-11-14+2031-11-14+N/A+2033-11-14 benralizumab 204008 Fasenra@@ -349,24 +340,6 @@ 2027-03-02 N/A 2029-03-02-botulism antitoxin heptavalent C/ D/F/ G – (equine)-190645-Bat-Emergent BioSolutions Inc.-N/A-2016-12-08-2022-12-08-Yes-2025-06-08-brexpiprazole-192684-Rexulti-Otsuka Pharmaceutical Co. Ltd.-N/A-2017-02-16-2023-02-16-Yes-2025-08-16 brexucabtagene autoleucel 246355 Tecartus@@ -403,6 +376,15 @@ 2026-03-12 N/A 2028-03-12+bulevirtide acetate+293441+Hepcludex+Gilead Sciences Canada, Inc.+N/A+2025-08-08+2031-08-08+N/A+2033-08-08 burosumab 216239 Crysvita@@ -563,8 +545,8 @@ N/A 2024-06-20 2030-06-20-N/A-2032-06-20+Yes+2032-12-20 ciltacabtagene autoleucel 262122 Carvykti@@ -574,6 +556,15 @@ 2029-02-09 N/A 2031-02-09+cipaglucosidase alfa+284815+Pombiliti+Amicus Therapeutics Canada Inc.+N/A+2025-04-14+2031-04-14+N/A+2033-04-14 clascoterone 265619 Winlevi@@ -610,24 +601,15 @@ 2024-06-07 Yes 2026-12-07-cysteamine bitartrate-191347-Procysbi-Horizon Pharma Ireland Ltd.-N/A-2017-06-13-2023-06-13-Yes-2025-12-13-fezolinetant-280470-Veozah-Astellas Pharma Canada, Inc.-N/A-2024-12-02-2030-12-02-N/A-2032-12-02+crovalimab+285444+Piasky+Hoffmann-La Roche Limited+N/A+2025-06-04+2031-06-04+Yes+2033-12-04 dacomitinib 214572 Vizimpro@@ -700,6 +682,15 @@ 2031-01-17 N/A 2033-01-17+delgocitinib+282015+Anzupgo+Leo Pharma Inc.+N/A+2025-08-25+2031-08-25+N/A+2033-08-25 deucravacitinib 259397 Sotyktu@@ -754,15 +745,6 @@ 2023-11-30 Yes 2026-05-30-durvalumab-202953-Imfinzi-AstraZeneca Canada Inc.-N/A-2017-11-03-2023-11-03-N/A-2025-11-03 ebola zaire vaccine (rVSVΔG-ZEBOV-GP, live) 256568 Ervebo@@ -781,15 +763,6 @@ 2024-10-03 N/A 2026-10-03-edoxaban-187363-Lixiana-Servier Canada Inc.-N/A-2016-11-04-2022-11-04-Yes-2025-05-04 efgartigimod alfa 267438 Vyvgart@@ -799,6 +772,15 @@ 2029-09-19 N/A 2031-09-19+elafibranor+287772+Iqirvo+Ipsen Biopharmaceuticals Canada Inc.+N/A+2025-04-25+2031-04-25+N/A+2033-04-25 elagolix 209513 Orilissa@@ -827,15 +809,15 @@ 2027-06-18 Yes 2029-12-18-eliglustat tartrate-183050-Cerdelga-Sanofi-Aventis Canada Inc.-N/A-2017-04-21-2023-04-21-N/A-2025-04-21+elinzanetant+289506+Lynkuet+Bayer Inc.+N/A+2025-07-23+2031-07-23+N/A+2033-07-23 elranatamab 273519 Elrexfio@@ -875,7 +857,7 @@ enfortumab vedotin 251438 Padcev-Seagen Inc.+Pfizer Canada ULC N/A 2021-10-29 2027-10-29@@ -1062,6 +1044,15 @@ 2027-04-22 Yes 2029-10-22+fezolinetant+280470+Veozah+Astellas Pharma Canada, Inc.+N/A+2024-12-02+2030-12-02+N/A+2032-12-02 fidanacogene elaparvovec 275853 Beqvez@@ -1083,7 +1074,7 @@ flibanserin 189352 Addyi-Searchlight Pharma Inc.+Sprout Pharmaceuticals, Inc. N/A 2018-02-27 2024-02-27@@ -1134,15 +1125,6 @@ 2030-09-10 N/A 2032-09-10-gadoterate meglumine-186333-Dotarem-Guerbet-N/A-2016-11-26-2022-11-26-Yes-2025-05-26 galcanezumab 219521 Emgality@@ -1152,6 +1134,15 @@ 2025-07-30 N/A 2027-07-30+garadacimab+280174+Andembry+CSL Behring Canada Inc.Diff output was truncated for readability.
